Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase 4 1Phase 2/3 1

Status

Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Plasma cell 1Lymphoid 1

Conditions

Breast Neoplasms 432Neoplasms 371Prostatic Neoplasms 205Lung Neoplasms 191Colorectal Neoplasms 153Motor Activity 94Uterine Cervical Neoplasms 81Pancreatic Neoplasms 78Head and Neck Neoplasms 75Carcinoma, Non-Small-Cell Lung 72Brain Neoplasms 71Ovarian Neoplasms 65Carcinoma, Hepatocellular 54Colonic Neoplasms 50Rectal Neoplasms 49Neoplasm Metastasis 48Anxiety Disorders 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 44Glioblastoma 44Hematologic Neoplasms 41Depression 41Glioma 37Disease 37Melanoma 36Sarcoma 35Multiple Myeloma 35Stomach Neoplasms 34Carcinoma, Renal Cell 32Pain 31Urinary Bladder Neoplasms 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Cytokine Release Syndrome × 90 days × Clear all
NCT07499128 2026-06-01

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

National Institutes of Health Clinical Center (CC)

Phase NA Enrolling by invitation
136 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Cytokine Release Syndrome, Lymphoma, Multiple Myeloma, Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06377059 2026-05-15

Early Detection of Complications During Immunotherapy for Haematological Malignancy

Rigshospitalet, Denmark

Phase NA Recruiting
100 enrolled
Other hematologic neoplasm

Cytokine Release Syndrome, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡